The study shows that the brain hormone GHRH, which normally triggers growth hormone release, also affects cell stress pathways and helps keep lung blood vessels intact by boosting a protective protein called P53. Blocking GHRH with antagonists reduced inflammation and could protect against severe lung damage like ARDS, but the work is still early and not a ready‑to‑use treatment for everyday health hacking.

Growth hormone-releasing hormone is a hypothalamic neuropeptide, which regulates the secretion of growth hormone by the anterior pituitary gland. Recent evidence suggest that it exerts growth factor activities in a diverse variety of in vivo and in vitro experimental malignancies, which are counteracted by growth hormone-releasing hormone antagonists. Those peptides support lung endothelial barrier integrity by suppressing major inflammatory pathways and by inducing the endothelial defender P53. The present effort provides information regarding the effects of growth hormone-releasing hormone in the regulation of P53 and the unfolded protein response. Furthermore, it suggests the possible application of growth hormone-releasing hormone antagonists towards the management of acute lung injury, including the lethal acute respiratory distress syndrome.